-Protein expression and purification
The pVHL:ElonginC:ElonginB (VCB) complex for biophysical and crystallization studies was obtained as previously described. 1, 2 For 15 N fully-labeled VCB protein preparation, the following minimal medium was used: 6 g/L Na 2 
-Chemicals and synthesis
All reagents and solvents were obtained from commercial sources, and used as supplied unless otherwise indicated. Reactions requiring anhydrous conditions were conducted in heated glassware (heat gun), under an inert atmosphere (argon), and using anhydrous solvents. CH 2 Cl 2 , toluene and MeOH were distilled over CaH 2 . Et 2 O was distilled on CaH 2 /LiAlH 4 . All reactions were monitored by analytical thin-layer chromatography (TLC) using indicated solvent systems on E. Merck silica gel 60 F254 plates (0.25 mm). TLC plates were visualized using UV light (254 nm) and/or by staining in potassium permanganate followed by heating. Solvents were removed by rotary evaporator below 40˚C and the compounds further dried using high vacuum pumps. 1 H and 13 C NMR were recorded on a Bruker Advance 400 MHz and 100 MHz NMR spectrometer respectively. Chemical shifts (δ H) are quoted in ppm (parts per million) and referenced to residual solvent signals: 1 To a room temperature suspension of 2-(3-methylisoxazol-5-yl)acetic acid, 12 (1.0 g, 7.09 mmol, 1 eq.) in freshly distilled CH 2 Cl 2 (30 mL), under inert atmosphere (argon), were successively added N-hydroxysuccinimide (1.06 g, 9.21 mmol, 1.3 eq) and N- -N'-ethylcarbodiimide hydrochloride (1.49 g, 7.80 mmol, 1.1 eq.). The resulting mixture was stirred at rt for 4.5 hours. (2S,4R)-benzyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride (2.01 g, 7.80 mmol, 1.1 eq) and N,Ndiisopropylethylamine (2.59 mL, 14.9 mmol, 2.1 eq.) were then added, and the resulting mixture was stirred at rt for 18 hours. The organic phase was washed with saturated aqueous NaHCO 3 (50 mL) and the phases were separated. The aqueous phase was extracted further with CHCl 3 (3 x 50 mL). The combined organic phases were dried (MgSO 4 ) and concentrated in vacuo. The product 15 (1.85 g, 76%) was obtained as an amorphous off white solid after flash column chromatography (100% AcOEt). R f 0. To a solution of (2S,4R)-benzyl 4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxylate, 15 (700 mg, 2.03 mmol, 1 eq.) in freshly distilled and degassed (bubbling with argon) MeOH (9.8 mL) at 0°C and under inert atmosphere (argon), was added 10% palladium on charcoal (107 mg, 0.102 mmol, 0.05 eq.). The resulting mixture was saturated with hydrogen (bubbling) and was stirred for 1.25 hour at 0°C under hydrogen atmosphere. The mixture was then degassed (bubbling with argon), filtered on celite and concentrated in vacuo. (2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxylic acid, 16 was obtained as a white solid and used for the next step without further purification. A 
(2S,4R)-4-hydroxy-N-methyl-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxamide, 5
To a room temperature suspension of (2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxylic acid, 16 (0.48 mmol, 1 eq.) in CHCl 3 (3.2 mL) , under inert atmosphere (argon), were successively added Nhydroxysuccinimide (65 mg, 0.57 mmol, 1.3 eq.) and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (92 mg, 0.48 mmol, 1.1 eq.). The resulting mixture was stirred at room temperature for 3 hours. Methylamine (8M in EtOH, 82 μL, 0.65 mmol, 1.5 eq.) and N,N-diisopropylethylamine (91 μL, 0.52 mmol, 1.2 eq.) were then 
N-(4-(4-methylthiazol-5-yl)benzyl)acetamide, 8
To a room temperature suspension of (4-(4-methylthiazol-5-yl)phenyl)methanamine, 18 (100 mg, 0.49 mmol, 1 eq.) in CH 2 Cl 2 (6 mL) under inert atmosphere (argon), was added triethylamine (147 µL, 107 mg, 1.06 mmol). The resulting mixture was stirred at room temperature for 10 minutes. Anhydride acetic was added dropwise and the resulting mixture was stirred at room temperature for 18 hours. The reaction was quenched with 10% HCl (5 mL) and the aqueous layer was extracted with CH 2 Cl 2 (3x10 mL). The combined organic layers were dried (MgSO 4 ) and concentrated in vacuo to give the product 8 (99 mg, 82% isolated) as a yellow pale solid after flash column chromatography (gradient 100 CH 2 
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To a room temperature suspension of (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid (200 mg, 1.15 mmol, 1 eq.) in CH 2 Cl 2 (3 mL), under inert atmosphere (argon), were successively added N-hydroxysuccinimide (172 mg mg, 1.50 mmol, 1.3 eq.) and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (241 mg, 1.26 mmol, 1.1 eq). The resulting mixture was stirred at room temperature for 3 hours. (4-(4-methylthiazol-5-yl)phenyl)methanamine, 18 (283 mg, 1.38 mmol, 1.2 eq.) dissolved with CH 2 Cl 2 (2 mL) and N,N-diisopropylethylamine (91 μL, 0.523 mmol, 1.2 eq.) were then added, and the resulting mixture was stirred at room temperature for 18 hours. The reaction mixture was diluted with CH 2 Cl 2 (5 mL) and washed with saturated aqueous NaHCO 3 (10 mL) and extracted with CH 2 Cl 2 (3x10 mL). The combined organic phases were dried (MgSO 4 ) and concentrated in vacuo to give the product 3 (133 mg, 32% isolated) as a white solid after flash column chromatography ( 
3-NMR experiments
All ligand-based NMR experiments were carried out at 278 K using Bruker Avance 500 MHz with TCI cryoprobe. Protein-based 1 H-15 N 2D NMR HSQC (correlation via double inept transfer, phase sensitive and with decoupling during acquisition) were performed at 305 K on Bruker Avance 700 MHz with TCI cryoprobe (Department of Chemistry, University of Cambridge).
1 H-15 N 2D NMR HSQC spectra were performed with 64 scans for each of 256 points in indirect dimension and relaxation delay of 1 s that summed up to 5 h of experiment time for each protein spectrum and titration. 
-X-ray diffraction experiments
The X-ray data collection and statistics for VCB crystals soaked with 2 (pdb code 3zrc) and 6 (pdb code 4awj) have been described previously.
1,2
In order to collect data for the 4 and 5 bound VCB complexes, VCB crystals were soaked overnight in a 20 mM solution of 4 or 5, in Na cacodylate pH 6.0, 15% PEG3350, 0.2 M Mg acetate, 5 mM DTT. X-ray data were collected at 100 K at the Diamond synchrotron facilities and processed using XDS. The structures were solved by rigid body refinement using Buster TNT 4 using the VCB apo structure (PDB code 3zrf)
1 as a starting model. The initial structure obtained this way was further refined using Buster TNT and corrected manually using Coot. 5 Data collection statistics and refinement parameters are summarized in Table S1 . ITC traces together with the results of the data fitting are shown in the Figures S1-S13. Figure S1 : Binding detection using ligand-based NMR spectroscopy for 1. Panels a), b) and c) depict spectra for VCB+1 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). d) Direct ITC titration for 1 (1 mM compound and 100 μM VCB). K a = 6.3 × 10 5 ± 3.5 × 10 4 M -1 ; ΔH = -5435 ± 25 cal/mol and ΔS = 8.3 cal/mol/degree. e) Modeled bound 1 (white carbon sticks) into VCB structure. The protein surface is shown in blue at 30% transparency. e) Figure S2 : a) Zoom on the 2D 1 H-15 N HSQC spectrum of 100 μM VCB (red) highlighting the residues shifting due the protein-ligand interaction with 1 mM concentration of 1 (blue). b) Site specific mapping into the VCB structure of the residues involved in the interaction (red). : Binding detection using ligand-based NMR spectroscopy for 2. Panels a), b) and c) depict spectra for VCB+2 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+2 using set-up 3 (red) and compound alone (blue). g) Direct ITC titration for 2 (1 mM compound and 100 μM VCB). K a = 1.8 × 10 5 ± 3.0 × 10 4 M -1 ; ΔH = -12150 ± 671 cal/mol and ΔS = -16.7 cal/mol/degree. h) Crystal structure of VCB in complex with 2 (cyan carbon sticks). 1 The protein surface is shown in green at 40% transparency.
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Figure S4: Binding detection using ligand-based NMR spectroscopy for 3. Panels a), b) and c) depict spectra for VCB+3 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). d) Direct ITC titration for 3 (3 mM compound and 100 μM VCB). K a = 2.7 × 10 4 ± 5.4 × 10 3 M -1 ; ΔH = -3200 ± 472 cal/mol and ΔS = 6.4 cal/mol/degree. e) Modeled bound 3 (white carbon sticks) into VCB structure. The protein surface is shown in blue at 30% transparency. e)
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Figure S5: Binding detection using ligand-based NMR spectroscopy for 5. Panels a), b) and c) depict spectra for VCB+5 using set-ups 1 and 2 (red and black respectively), the compound alone (blue). d) Direct ITC titration for 5 (3 mM compound and 100 μM VCB). K a = 4.17 × 10 3 ± 293 M -1 ; ΔH = -2555 ± 259 cal/mol and ΔS = 8.0 cal/mol/degree. e) Crystal structure of VCB in complex with 5 (blue carbon sticks). The omit electron density maps (F o -F c ) is shown in green contoured at 2.5σ around the ligand. The protein surface is shown in green at 40% transparency. 
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Figure S6: Binding detection using ligand-based NMR spectroscopy for 6. Panels a), b) and c) depict spectra for VCB+6 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+6 using set-up 3 (red) and compound alone (blue). g) Direct ITC titration for 6 (60 mM compound and 100 μM VCB). K a = 204 ± 19.7 M -1 ; ΔH = -2415 ± 153 cal/mol and ΔS = -16.7 cal/mol/degree. h) Competitive ITC titration between 2 and 6. Direct titration of 2 into 100 μM VCB is shown in the absence (black trace) and presence (red trace) of 3 mM of 6. i) Crystal structure of VCB in complex with 2 (orange carbon sticks). 2 The protein surface is shown in green at 40% transparency.
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Figure S7: Binding detection using ligand-based NMR spectroscopy for 7. Panels a), b) and c) depict spectra for VCB+7 using set-ups 1 and 2 (red and black respectively) and the compound alone (blue). Panels d), e) and f) depict spectra for VCB+7 using set-up 3 (red) and compound alone (blue).
Figure S8:
Binding detection using ligand-based NMR spectroscopy for 8. Panels a), b) and c) depict spectra for VCB+8 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+8 using set-up 3 (red) and compound alone (blue). g) Competitive ITC titration between 2 and 8. Direct titration of 2 into 100 μM VCB is shown in the absence (black trace) and presence (red trace) of 3 mM of 8. h) 1 H-15 N HSQC of 0.3 mM VCB (black contours) and when titrated with 5 mM of 8 (red contours). 
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Figure S9: Binding detection using ligand-based NMR spectroscopy for 9. Panels a), b) and c) depict spectra for VCB+9 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+9 using set-up 3 (red) and compound alone (blue).
Figure S10: Binding detection using ligand-based NMR spectroscopy for 10. Panels a), b) and c) depict spectra for VCB+10 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+10 using set-up 3 (red) and compound alone (blue).
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Figure S11: Binding detection using ligand-based NMR spectroscopy for 11. Panels a), b) and c) depict spectra for VCB+11 using set-ups 1 and 2 (red and black respectively), the compound alone (blue) and in competition with 100 μM 19-mer HIF-1α peptide under set-up 2 (green). Panels d), e) and f) depict spectra for VCB+11 using set-up 3 (red) and compound alone (blue). g) Competitive ITC titration between 2 and 11. Direct titration of 2 into 100 μM VCB is shown in the absence (black trace) and presence (red trace) of 3 mM of 11.
Figure S12: Binding detection using ligand-based NMR spectroscopy for 12. Panels a), b) and c) depict spectra for VCB+12 using set-ups 1 and 2 (red and black respectively). Panels d), e) and f) depict spectra for VCB+12 using set-up 3 (red) and compound alone (blue) 
